Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion.

Journal: Hepatobiliary surgery and nutrition
Published Date: Dec 1, 2018

Abstract

BACKGROUND: The survival benefit of postoperative adjuvant transcatheter arterial chemoembolization (PA-TACE) remained controversial. We aimed to investigate the prognosis effect of PA-TACE on the Barcelona Clinic Liver Cancer (BCLC) early stage multinodular hepatocellular carcinoma (MHCC) patients with/without microvascular invasion (MVI).

Authors

  • Han Wang
    Saw Swee Hock School of Public Health, National University Health System, National University of Singapore, Singapore.
  • Peng-Cheng Du
    Department of Vascular Surgery, Changhai Hospital, The Second Military Medical University, Yangpu, Shanghai 200433, China.
  • Meng-Chao Wu
    Department of Surgery, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Yangpu, Shanghai 200433, China.
  • Wen-Ming Cong
    Department of Pathology, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Yangpu, Shanghai 200438, China.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals